Table 3.
Frequency (kHz) | Hypertension at Visit 1 | Hypertension at Visit 5 | ||
---|---|---|---|---|
Estimate [dB HL] (95% CI) | P-value | Estimate [dB HL] (95% CI) | P-value | |
0.5 | −2.57 (−6.65, 1.52) | 0.219 | 2.48 (−1.13, 6.10) | 0.179 |
1 | 3.39 (0.71, 6.06) | 0.013 | 1.40 (−1.00, 3.81) | 0.252 |
2 | 4.18 (−0.42, 8.78) | 0.075 | 1.18 (−2.92, 5.28) | 0.572 |
4 | 7.68 (2.41, 12.95) | 0.004 | −1.91 (−6.63, 2.81) | 0.428 |
8 | 9.01 (3.12, 14.89) | 0.003 | 0.55 (−4.74, 5.85) | 0.838 |
P-interactionc | 0.006 | 0.309 |
Estimated from linear mixed effects models
Hearing impairment was measured at Visit 5. Hypertension defined as systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥90 mmHg, or antihypertensive use. Model adjusts for age, sex, education, smoking status and diabetes status
P-interaction to test whether the association between hypertension and hearing loss differs by frequency